BEGIN:VCALENDAR PRODID;X-RICAL-TZSOURCE=TZINFO:-//com.denhaven2/NONSGML ri_cal gem//EN CALSCALE:GREGORIAN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:We Need More Cowbell! \; Riders of the annual Tri-State T rek cycle 270 miles from Boston to New York\, making noise and raising m oney to end ALS\, Lou Gehrig&rsquo\;s disease. \; Come to ride\, vol unteer\, or just cheer! \; \; \; \; \;\n \;\n- J uly 22 &ndash\; 24\, 2011\n- 3 days/270 miles\n- www.NeedMoreCowebell.or g\n- NeedMoreCowbell@als.net\n- 617-441-7200\n- Funds raised benefit the ALS Therapy Development Institute \;\nAbout ALS\nAmyotrophic latera l sclerosis (ALS\, Lou Gehrig&rsquo\;s disease) is a progressive neurode generative disease that leads to paralysis\, due to the death of motor n eurons in the spinal cord and brain. There is no known cause\, cure or e ffective treatment for the disease. About 5\,000 people in the US are di agnosed with ALS each year\; the incidence is similar to Multiple Sclero sis. However\, with no effective treatment and an aggressive and rapid d isease progression\, the average patient survives only 2-5 years followi ng their diagnosis. There are about 30\,000 US citizens diagnosed with t he disease at any given time. The worldwide population of ALS patients i s estimated at 400\,000.\n \;\nAbout ALS Therapy Development Institu te (ALS TDI)\nThe mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS\, Lou Gehrig&rsquo\;s disease) as soon as possibl e for patients today. Focused on meeting this urgent unmet medical need\ , ALS TDI executes a robust target discovery program\, while simultaneou sly operating the world&rsquo\;s largest efforts to preclinically valida te potential therapeutics\; including a pipeline of dozens of small mole cules\, protein biologics\, gene therapies and cell-based constructs. Th e world&rsquo\;s first nonprofit biotech institute\, ALS TDI has develop ed an industrial-scale platform\, employs 30 professional scientists and evaluates dozens of potential therapeutics each year. Built by and for patients\, the Cambridge\, Massachusetts based research institute collab orates with leaders in both academia and industry to accelerate ALS ther apeutic development\, including Biogen Idec\, UCB\, Aestus Therapeutics\ , MDA and RGK Foundation. For more information\, please visit us online at www.als.net.\n \; URL:http://fortlee.patch.com/events/tri-state-trek-bike-ride-a121ed5f SUMMARY:Tri-State Trek Bike Ride LOCATION:350 Washington St\, Newton\, MA 02458: 350 Washington St\, Newto n\, MA END:VEVENT END:VCALENDAR